R & D Portfolio Management

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

R & D Portfolio Management, Executive SummaryOverviewOverviewKey FindingsDecision AnalysisImplicationsR & D Portfolio Management, IntroductionIntroduction to R & D Portfolio ManagementReport Aim and PurposeResearch MethodologyDefining R & D Portfolio ManagementPortfolio AnalysisHistory of Portfolio ManagementR & D Portfolio Management, Drivers and Restraints for Portfolio ManagementDrivers for Portfolio ManagementRevenue to Cost RatiosStrong Stock Market FocusDecrease in NCEs Reaching the MarketPatent Expiry of BlockbustersEvaluating Growth Opportunities in ContextScope for Improved EfficiencyRestraints for Portfolio ManagementStructural ChallengesPM Models Focus on Optimisation of Existing AssetsCost of ImplementationDecision AnalysisR & D Portfolio Management, Current Practices Survey ResultsCurrent Practices in Portfolio ManagementObjective of Current Practice InvestigationScreening Criteria UsedSurvey ResultsR & D Portfolio Management, Strategic Portfolio ManagementObjectives of Portfolio managementMotivation for Strategic Portfolio ManagementMaximising ValueBalanceStrategyR & D Portfolio Management, Operational Portfolio ManagementImplementing StrategyAnalysing ProjectsRisks and UncertaintiesInterdependence of ProjectsDecision AnalysisDecision Analysis OverviewNet Present ValueDecision TreeOption ApproachSimulationNon-financial ModelsMarket ResearchImpact of Market ResearchImproving Accuracy in Portfolio ManagementR & D Portfolio Management, Portfolio Analysis for Selected CompaniesAventis - Analysis of Diabetes PortfolioAventis OverviewWorld Diabetes MarketUnmet NeedsAventis' Diabetes PortfolioPortfolio Analysis: Aventis vs. Eli LillyPfizer and Pharmacia MergerPfizer and Pharmacia Background for the MergerBenefits from MergingPortfolio Management ImplementationImpact on Total Pharmaceutical MarketR & D Portfolio Management, Future for Portfolio ManagementFuture Developments for Portfolio ManagementBetter Tools for Managing Portfolios




Related Research

Release Date : 13-Oct-17

Region : Global

Release Date : 13-Oct-17

Region : Global

Release Date : 11-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.